Failure of  -adrenergic blocking agents to alter estrogenic induction of uterine enzymes.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002369:Castration; D000242:Cyclic AMP / Q000378:metabolism; D004347:Drug Interactions; D004790:Enzyme Induction / Q000187:drug effects*; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D006003:Glycogen / Q000096:biosynthesis; D006593:Hexokinase / Q000096:biosynthesis; D007545:Isoproterenol / Q000494:pharmacology; D009929:Organ Size; D010732:Phosphofructokinase-1 / Q000096:biosynthesis; D011433:Propranolol / Q000494:pharmacology; D011770:Pyruvate Kinase / Q000096:biosynthesis; D051381:Rats; D013997:Time Factors; D014599:Uterus / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D004958:Estradiol; D006003:Glycogen; D011433:Propranolol; D000242:Cyclic AMP; D006593:Hexokinase; D010732:Phosphofructokinase-1; D011770:Pyruvate Kinase; D007545:Isoproterenol